CD8A and neoplasm: Eric Tran et al. identified a polyclonal CD8 + T-cell response against mutant KRAS G12D in tumor-infiltrating lymphocytes obtained from a patient with metastatic colorectal cancer [14].These findings demonstrate that neoantigen vaccines may hold great potential for the treatment of a variety of tumors, including colorectal cancer.